UK trial looks into benefit of third dose
2021-06-17 00:00
The United Kingdom has launched a trial into COVID booster jabs that will assess if a third dose of a vaccine can help extend protection against the novel coronavirus.In the UK governmentbacked trial, which launched this week, more than , participants will receive a third COVID shot  to  weeks after a second dose. Researchers will then monitor participants immune responses over time.The trial, which is currently reserved for people who are older than , will initially assess seven vaccinesPfizer, Moderna, Janssen, AstraZeneca, Novavax, Valneva, and CureVacas booster candidates.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html